Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Kayla M Parker, Thanh D Dang, Rushani Wijesuriya, Victoria X Soriano, Adrian J Lowe, Shyamali C Dharmage, Paxton Loke, Mimi L K Tang, Katie J Allen, Jennifer J Koplin, Kirsten P Perrett, Rachel L Peters
BACKGROUND: There are no studies of longitudinal immunoglobulin measurements in a population-based cohort alongside challenge-confirmed peanut allergy outcomes. Little is known about biomarkers for identifying naturally resolving peanut allergy during childhood. OBJECTIVES: To measure longitudinal trends in whole peanut and component Ara h 2 sIgE and sIgG4 in the first 10 years of life, in a population cohort of children with challenge-confirmed peanut allergy, and to determine whether peanut-specific immunoglobulin levels or trends are associated with peanut allergy persistence or resolution by 10 years of age...
May 8, 2024: Allergy
#2
Zsófia Unger, Alina Kuklinski, Cristina Gomez-Casado
No abstract text is available yet for this article.
May 7, 2024: Allergy
#3
JOURNAL ARTICLE
Stephan Flory, Bjarke Hviid-Vyff, Lara Šošić, Johannes M Schmid, Lars Ahlbeck, Emma C J Widmer, Claudia C V Lang, Kristian Ikenberg, Thomas M Kündig, Hans Jürgen Hoffmann, Pål Johansen
BACKGROUND: Intralymphatic immunotherapy (ILIT) represents a promising novel approach treating allergic diseases. However, no standardized procedures or recommendations have been established or reported, despite the recognized fact that treatment efficacy relies on the ability to inject the allergen intranodally. OBJECTIVE: We aim to provide a critical appraisal of ILIT as a method of allergen immunotherapy and to deliver practical recommendations for accurate ILIT...
May 7, 2024: Allergy
#4
LETTER
D Stölzl, N Sander, D Siegels, I Harder, B Kind, M Fonfara, L Heinrich, S Abraham, I Neustädter, A Kleinheinz, S Gerdes, A Wollenberg, S Lau, K Nemat, A Heratizadeh, I Gellhaus, T Werfel, J Schmitt, S Weidinger
No abstract text is available yet for this article.
May 7, 2024: Allergy
#5
LETTER
Michalina Sypka, Marianne Zwicker, Sophie Braga Lagache, Anne-Christine Uldry, Monique Vogel, Paul Engeroff
No abstract text is available yet for this article.
May 6, 2024: Allergy
#6
LETTER
Celeste Porsbjerg, Benedikt Fritzsching, Nick Freemantle, Marco Contoli, Andreas Kallsoy Slættanes, Christian Woehlk
No abstract text is available yet for this article.
May 5, 2024: Allergy
#7
EDITORIAL
María José Torres, Ludger Klimek, Ioana Agache, Marek Jutel, Mübeccel Akdis, Mohamed H Shamji, Cezmi A Akdis
No abstract text is available yet for this article.
May 3, 2024: Allergy
#8
JOURNAL ARTICLE
Oliver Pfaar, Bernardo Sousa-Pinto, Nikolaos G Papadopoulos, Désirée E Larenas-Linnemann, Michal Ordak, Maria J Torres, Ralph Mösges, Ludger Klimek, Torsten Zuberbier, Paolo M Matricardi, Uwe E Berger, Markus Berger, Stephanie Dramburg, Vera Mahler, Sanna K Toppila-Salmi, Karl-Christian Bergmann, Markus Ollert, Salvatore Tripodi, Marek Jutel, Ioana Agache, Ibon Eguiluz-Gracia, G Walter Canonica, Cezmi A Akdis, Milena Sokolowska, Mikhail Sofiev, Mohamed H Shamji, Wienczyslawa Czarlewski, Joao A Fonseca, Anna Bedbrook, Jean Bousquet
In rhinitis and asthma, several mHealth apps have been developed but only a few have been validated. However, these apps have a high potential for improving person-centred care (PCC), especially in allergen immunotherapy (AIT). They can provide support in AIT initiation by selecting the appropriate patient and allergen shared decision-making. They can also help in (i) the evaluation of (early) efficacy, (ii) early and late stopping rules and (iii) the evaluation of (carried-over) efficacy after cessation of the treatment course...
May 3, 2024: Allergy
#9
LETTER
Bogusia Kasternow, Da-In S Kim, Patrick F K Yong
No abstract text is available yet for this article.
May 3, 2024: Allergy
#10
Purificación Gonzalez-Delgado, Sara Anvari, Ana Entrala, Sonsoles Infante
No abstract text is available yet for this article.
April 30, 2024: Allergy
#11
JOURNAL ARTICLE
Emanuele Marchi, Timothy S C Hinks, Matthew Richardson, Latifa Khalfaoui, Fiona A Symon, Poojitha Rajasekar, Rachel Clifford, Beverley Hargadon, Cary D Austin, Julia L MacIsaac, Michael S Kobor, Salman Siddiqui, Jordan S Mar, Joseph R Arron, David F Choy, Peter Bradding
BACKGROUND: The effects of inhaled corticosteroids (ICS) on healthy airways are poorly defined. OBJECTIVES: To delineate the effects of ICS on gene expression in healthy airways, without confounding caused by changes in disease-related genes and disease-related alterations in ICS responsiveness. METHODS: Randomized open-label bronchoscopy study of high-dose ICS therapy in 30 healthy adult volunteers randomized 2:1 to (i) fluticasone propionate 500 mcg bd daily or (ii) no treatment, for 4 weeks...
April 30, 2024: Allergy
#12
JOURNAL ARTICLE
Madhuri Amulya Koduri, Tejaswini Pingali, Deeksha Prasad, Vijay Singh, Swati Singh, Swapna S Shanbhag, Sayan Basu, Vivek Singh
PURPOSE: This study aims to elucidate the tear proteome and understand the underlying molecular mechanisms involved in the ocular complications following Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). METHODS: Mass spectrometry (MS) was performed to quantify the tear fluid proteins from chronic SJS/TEN patients (n = 22 eyes) and age- and gender-matched controls (n = 22 eyes). The candidate proteins were validated using ELISA (n = 80 eyes) in tear samples and immunohistochemistry (IHC; n = 12) in eyelid margin specimens...
April 29, 2024: Allergy
#13
JOURNAL ARTICLE
Jose A Céspedes, Rubén Fernández-Santamaría, Gador Bogas, Adriana Ariza Veguillas, Inmaculada Doña, María Salas, Marina Labella, Tahia D Fernández Duarte, Cristobalina Mayorga, María J Torres, Cecilia A Frecha
No abstract text is available yet for this article.
April 27, 2024: Allergy
#14
Shifaa Alkotob, Philippe Bégin, Aikaterini Anagnostou
No abstract text is available yet for this article.
April 27, 2024: Allergy
#15
LETTER
Erik Sören Halvard Hansen, Hannah Kaiser, Kristine Tronier Hansen, Klaus Bønnelykke, Bo Chawes, Vibeke Backer, Christian Torp-Pedersen, Charlotte Suppli Ulrik, Nicklas Brustad
No abstract text is available yet for this article.
April 27, 2024: Allergy
#16
Ana M Pérez-Moreno, Pablo Torres, Juan L Paris
No abstract text is available yet for this article.
April 26, 2024: Allergy
#17
JOURNAL ARTICLE
Mayumi Ueta, Yasuhito Watanabe, Charles Melby-Thompson, Chie Sotozono, Shigeru Kinoshita
No abstract text is available yet for this article.
April 25, 2024: Allergy
#18
JOURNAL ARTICLE
Axel Luyten, Alexandra Bürgler, Sarah Glick, Marek Kwiatkowski, Regula Gehrig, Minaya Beigi, Karin Hartmann, Marloes Eeftens
BACKGROUND: Ambient pollen exposure causes nasal, ocular, and pulmonary symptoms in allergic individuals, but the shape of the exposure-response association is not well characterized. We evaluated this association and determined (1) whether symptom severity differs between subpopulations; (2) how the association changes over the course of the pollen season; and (3) which pollen exposure time lags affect symptoms. METHODS: Adult study participants (n = 396) repeatedly scored severity of nasal, ocular, and pulmonary allergic symptoms, resulting in three composite symptom scores...
April 24, 2024: Allergy
#19
LETTER
Alain Michils, Jean-Pierre Makhoul, Nathan Blekic, Amaryllis Haccuria, Silvia Perez-Bogerd, Andreï Malinovschi, Alain Van Muylem
No abstract text is available yet for this article.
April 24, 2024: Allergy
#20
JOURNAL ARTICLE
Parameswaran Nair, Katherine Radford, Satoshi Nunomura, Manali Mukherjee, Kenji Izuhara
No abstract text is available yet for this article.
April 23, 2024: Allergy
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
